Loading clinical trials...
Loading clinical trials...
On the Regulation of Hepatic Glucose Metabolism During Insulin-induced Hypoglycemia
Conditions
Interventions
Saline
C-peptide
Locations
1
United States
University of Cincinnati
Cincinnati, Ohio, United States
Start Date
June 1, 2024
Primary Completion Date
June 1, 2027
Completion Date
January 1, 2028
Last Updated
February 17, 2026
NCT07224321
NCT07395050
NCT07457580
NCT06815081
NCT06474598
NCT03970720
Lead Sponsor
University of Cincinnati
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions